Prodigi
Payments companies reported to CMS as associated with Prodigi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prodigi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prodigi
These are the largest totals companies reported as associated with Prodigi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joo Hwang | Stanford, CA | Gastroenterology (Internal Medicine) | $4,174.93 |
| Veeral Oza | Greenville, SC | Gastroenterology (Internal Medicine) | $1,243.38 |
| Antonio Mendoza Ladd | Sacramento, CA | Gastroenterology (Internal Medicine) | $1,243.38 |
| Amit Bhatt | Cleveland, OH | Gastroenterology (Internal Medicine) | $312.47 |
| Nikhil Kumta | New York, NY | Gastroenterology (Internal Medicine) | $293.79 |
| Peter Draganov | Gainesville, FL | Gastroenterology (Internal Medicine) | $292.25 |
| Amit Bhatt | Houston, TX | Ophthalmology | $235.12 |
| Dayna Early | Saint Louis, MO | Gastroenterology (Internal Medicine) | $153.32 |
| Gabriel Lang | Saint Louis, MO | Gastroenterology (Internal Medicine) | $153.32 |
| Judy Trieu | Saint Louis, MO | Gastroenterology (Internal Medicine) | $153.32 |
Prescribed Prodigi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.